Patent: 10,005,783
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 10,005,783
Title: | Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds |
Abstract: | Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal. |
Inventor(s): | Haas; Julia (Boulder, CO), Andrews; Steven W. (Boulder, CO), Jiang; Yutong (Boulder, CO), Zhang; Gan (Boulder, CO) |
Assignee: | Array BioPharma Inc. (Boulder, CO) |
Application Number: | 15/399,389 |
Patent Claims: | see list of patent claims |
Details for Patent 10,005,783
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | See Plans and Pricing | 2028-10-22 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | See Plans and Pricing | 2028-10-22 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | See Plans and Pricing | 2028-10-22 |
Genentech, Inc. | PERJETA | pertuzumab | Injection | 125409 | 06/08/2012 | See Plans and Pricing | 2028-10-22 |
Genentech, Inc. | KADCYLA | ado-trastuzumab emtansine | For Injection | 125427 | 02/22/2013 | See Plans and Pricing | 2028-10-22 |
Genentech, Inc. | RITUXAN HYCELA | rituximab and hyaluronidase human | Injection | 761064 | 06/22/2017 | See Plans and Pricing | 2028-10-22 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |